Showing results (51-60 of 144) with videos related to

Sort By:
Pageof 15
The Journal of Antimicrobial Chemotherapy|February 7, 2001
In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilmM H Wilcox, P Kite, K Mills, et al.
Journal of Clinical Pathology|March 1, 1996
Effect of pH changes in cerebrospinal fluid specimens on bacterial survival and antigen test resultsJ G Cunniffe, S Whitby-Strevens, M H Wilcox
The Journal of Antimicrobial Chemotherapy|August 2, 2001
A comparison of culture and PCR to determine the prevalence of ampicillin-resistant bacteria in the faecal flora of general practice patientsJ Heritage, N Ransome, P A Chambers, et al.
Infection Prevention in Practice|July 28, 2021
Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2C M Rooney, J McIntyre, L Ritchie, et al.
The Journal of Hospital Infection|September 1, 1996
Financial burden of hospital-acquired Clostridium difficile infectionM H Wilcox, J G Cunniffe, C Trundle, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 18, 2016
Evaluation of the novel artus C. difficile QS-RGQ, VanR QS-RGQ and MRSA/SA QS-RGQ assays for the laboratory diagnosis of Clostridium difficile infection (CDI), and for vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) screeningK A Morris, L R Macfarlane-Smith, M H Wilcox
The Journal of Hospital Infection|December 27, 2005
Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocinW N Fawley, P Parnell, J Hall, et al.
The Journal of Hospital Infection|July 6, 2014
Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/counterpoint reviewS Harbarth, S Tuan Soh, C Horner, et al.
Pageof 15